User Fees Won't Save FDA Approvals From Shutdown's Snare

Law360, New York (October 01, 2013, 12:08 AM ET) -- Given its reliance on industry fees, the U.S. Food and Drug Administration will be less hampered by the government shutdown than other federal agencies, but attorneys say that funding and manpower shortages could still hurt companies with drugs or other products in the approval pipeline, especially those toward the beginning of the process.

Large portions of the federal government closed after midnight on Tuesday after Congress failed to reach a bipartisan agreement to fund their operation. Compared to other agencies, the shutdown's effect on the FDA...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required